We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPTH
11751
DELISTED
Bio-Path Holdings Inc
BPTH
$35K ﹤0.01%
+545
New +$41.4K
CELL
11752
PUT
DELISTED
PhenomeX Inc. Common Stock
CELL
$35K ﹤0.01%
12,300
-8,000
-39% -$34K
EBET
11753
CALL
DELISTED
EBET, INC. Common Stock
EBET
$35K ﹤0.01%
957
+377
+65% +$23.4K
STCN
11754
CALL
DELISTED
Steel Connect, Inc. Common Stock
STCN
$35K ﹤0.01%
2,721
-354
-12% -$4.48K
VLTA
11755
PUT
DELISTED
Volta Inc.
VLTA
$35K ﹤0.01%
29,100
-8,900
-23% -$18K
FCRD
11756
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$35K ﹤0.01%
+12,135
New +$39.9K
CEMI
11757
DELISTED
Chembio diagnostics, Inc.
CEMI
$35K ﹤0.01%
95,977
+78,012
+434% +$53.2K
AFMD
11758
CALL
DELISTED
Affimed
AFMD
$34K ﹤0.01%
1,630
-1,440
-47% -$40K
ALZN icon
11759
CALL
Alzamend Neuro
ALZN
$7.43M
$34K ﹤0.01%
21
-13
-38% -$17.9K
NKTR icon
11760
PUT
Nektar Therapeutics
NKTR
$2.47B
$34K ﹤0.01%
700
-2,093
-75% -$125K
TEF
11761
CALL
DELISTED
Telefonica
TEF
$34K ﹤0.01%
+10,500
New +$44.5K
VSTM icon
11762
PUT
Verastem
VSTM
$596M
$34K ﹤0.01%
3,317
+342
+11% +$4.77K
VVOS icon
11763
Vivos Therapeutics
VVOS
$4.77M
$34K ﹤0.01%
+2,086
New +$63.5K
WTT
11764
CALL
DELISTED
Wireless Telecom Group, Inc.
WTT
$34K ﹤0.01%
26,500
+4,600
+21% +$6.41K
MTL
11765
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$34K ﹤0.01%
41,153
IBIO icon
11766
iBio
IBIO
$71M
$33K ﹤0.01%
384
-1,025
-73% -$141K
ICAD
11767
DELISTED
iCAD Inc
ICAD
$33K ﹤0.01%
15,754
-57,544
-79% -$188K
LPCN icon
11768
CALL
Lipocine
LPCN
$17.4M
$33K ﹤0.01%
4,282
-842
-16% -$9.4K
MKTW icon
11769
CALL
MarketWise
MKTW
$54.2M
$33K ﹤0.01%
720
-235
-25% -$13.9K
RGS icon
11770
CALL
Regis Corp
RGS
$69.3M
$33K ﹤0.01%
1,645
-875
-35% -$19.3K
SID icon
11771
PUT
Companhia Siderúrgica Nacional
SID
$1.17B
$33K ﹤0.01%
+13,700
New +$37.8K
SLNH icon
11772
Soluna Holdings
SLNH
$207M
$33K ﹤0.01%
763
-626
-45% -$54.7K
SUP
11773
CALL
DELISTED
Superior Industries International
SUP
$33K ﹤0.01%
+11,000
New +$48.6K
SVRA icon
11774
CALL
Savara
SVRA
$1.11B
$33K ﹤0.01%
21,000
+5,800
+38% +$9.34K
LFWD icon
11775
CALL
ReWalk Robotics
LFWD
$21M
$33K ﹤0.01%
438
+108
+33% +$8.9K

Similar funds

Citadel Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Citadel Advisors deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
  • Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Citadel Advisors opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.